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Summary
Molluscum contagiosum virus is a human and animal dermatotropic pathogen, which causes 
a severe disease in immunocompromised individuals. MCV belongs to the Poxviridae family 
whose members exert immunomodulatory effects on the host antiviral response. Poxvi-
ruses interfere with cell signaling pathways that lead to the activation of nuclear factor кB, 
a pleiotropic transcription factor which is crucial for regulation of the immune response, 
the cell cycle and apoptosis. In resting cells, NF-κB is present in the cytoplasm, where it is 
associated with inhibitor κB. Upon stimulation by activators, such as proinflammatory cy-
tokines and bacterial or viral products, the inhibitory protein undergoes phosphorylation 
and proteasomal degradation. NF-κB, in turn, translocates to the nucleus, where it regulates 
the transcription of various genes that are essential for processes mentioned above. Since 
poxviruses replicate exclusively in the cell cytoplasm, NF-кB became a good target for pox-
viral immunomodulation. MCV encodes various proteins which interfere with the signal-
ing pathways that lead to the activation of NF-κB. Ligand inhibitor encoded by MCV, MC54, 
binds interleukin-18 and inhibits interferon-γ production. Other MCV proteins, MC159 and 
MC160, belong to intracellular inhibitors of NF-κB and are members of viral FLICE-inhibi-
tory proteins (vFLIPs). MC159 protein encoded by MCV was shown to inhibit apoptosis of 
virus-infected cells. Such interactions serve immune evasion and are responsible for the 
persistence of MCV.
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IntroductIon
Molluscum contagiosum virus (MCV) is a dermatotropic patho-
gen that causes a skin disorder which is common in children 
and sexually active adults. The disease, called molluscum 
contagiosum, persists in individuals with a weakened im-
mune system and is known for its coexistence with AIDS. 
MCV spreads by both direct and indirect skin contact as well 
as during sexual activity [22,31]. Although MCV infection is 
not sexually transmitted per se, it is regarded as a marker 
for sexually transmitted diseases [11,37]. Moreover, cases 
of vertical transmission of molluscum infections have been 
reported [19]. MCV also infects animals, such as chickens, 
pigeons, sparrows, horses and dogs. The lesions which the 
virus evokes in humans and animals can be seen as small 
and waxy papules occurring mainly on the face and trunk, 
as well as in the oral cavity and genital region. They are small 
and discrete with central umbilication; however, in HIV-po-
sitive patients atypical large or nonumbilicated lesions can 
be observed [6,8,34].
There are at least three subtypes of MCV and two of them, 
MCV1 and MCV2, cause similar symptoms in humans [8, 
18]. In healthy individuals, molluscum contagiosum is a self-
-limiting viral skin infection that can be resolved within 
months, whereas in patients with atopic dermatitis or AIDS 
and in other immunocompromised persons the disease is 
more severe and prolonged [16,39]. Furthermore, the di-
sorder may cause complications, such as persistence and 
spread of lesions that can be recurrent. Additionally, it may 
be associated with secondary bacterial infections occurring 
in skin. The lesions can be removed surgically and various 
medications are used in order to eliminate warts. However, 
these methods may cause scarring or blistering [22]. Since 
treatments mentioned above rely on tissue destruction and 
result in infections and scarring, new therapeutic methods 
are being developed [20].
MCV is the only member of the Molluscipoxvirus genus of the 
Poxviridae family consisting of large dsDNA viruses, who-
se virions are brick-shaped or oval structures that can be 
seen under a light microscope. Poxviruses contain more 
than 130 genes in their genomes whose central part inc-
ludes conserved genes, which are mostly responsible for 
virus replication. In the terminal regions, in turn, unique 
genes involved in interactions between virus and host are 
present [4,7,18,40]. The non-conserved genes within the po-
xvirus genome are responsible for host range, pathogenesis 
and immunomodulation [33]. Although MCV lacks most of 
the immunomodulatory proteins that are encoded by other 
members of the Poxviridae family, its 190 kbp genome conta-
ins genes that are likely to encode 163 proteins, such as MC80 
(major histocompatibility complex class I (MHCI) homolog), 
MC148 (chemokine antagonist), and MC66 (glutathione pe-
roxidase homolog), which can be linked with coexistence 
with the host [23,35].
MCV replicates in vivo in human keratinocytes and is not able 
to replicate in vitro in cell or tissue cultures; however, it may 
induce a typical cytopathogenic effect in human primary 
fibroblast MRC5 and HEPM cells, but cannot be obtained 
in permanent human or simian-derived cell lines [3]. MCV 
replicates in the stratum spinosum, where virus-specific 
changes, such as viroplasm and virus particles, can be de-
tected. Molluscum bodies formed by virions and non-mem-
brane vacuoles are likely to expand due to the migration of 
the infected cell into the granular layer. The central core of 
the lesion, rich in virus, is formed by a disintegrated large 
inclusion body produced by the infected cell on the gate to 
the horny layer. The basement membrane, which separates 
the dermis from the epidermal basal layer, remains intact 
throughout infection, which may explain little or no inflam-
matory response and reinfection of the host [4].
nF-κΒ as a target For vIral Immunomodulatory proteIns
Poxviruses are well known for their immunomodulatory 
abilities that enable them to complete their replication cycle 
and spread within cells effectively. In order to control the 
host antiviral response, MCV and other members of the Pox-
viridae family exploit different strategies that are based on in-
hibition of host regulatory proteins, such as nuclear factor κB 
(NF-κΒ) transcription factor. The poxvirus replication cycle 
occurs in the cytoplasm only; thus NF-κΒ, which is activated 
within the cytosol, is a good target for various poxvirus in-
hibitors: ligand inhibitors, intracellular inhibitors of NF-κΒ, 
ankyrin repeat and PYRIN domain NF-κΒ inhibitors [21].
The mammalian NF-κΒ transcription factor family consists 
of five proteins – c-Rel, RelA (p65), RelB, NF-ĸB1 (p50) and 
NF-ĸB2 (p52) – which form homo- and heterodimers that 
are able to activate or inhibit transcription. The most abun-
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dant form of NF-κΒ that can be found in mammalian cells 
is p65/p50 heterodimer associated with its inhibitor, called 
inhibitor κB (IκΒ) [30]. The IκB proteins IκBα, IκΒβ, and IκBε, 
or p100 and p105 precursor proteins, maintain NF-κΒ di-
mers in the cytoplasm in an inactive state [12]. NF-κΒ ac-
tivation is triggered by proinflammatory cytokines, such 
as interleukin-1β (IL-1β), tumor necrosis factor-α (TNF-α), 
viral or bacterial products, and other stimuli that induce 
IκΒ phosphorylation by IкB kinase (IKK) complex consist-
ing of IKKα (IKK1) and IKKβ (IKK2) catalytic subunits and 
IKKγ (NF-κΒ essential modulator; NEMO) regulatory subunit. 
Upon activation, NF-κΒ dimer translocates to the nucleus 
and regulates transcription of target genes, which are cru-
cial for the cell cycle, apoptosis, inflammatory response and 
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Fig. 1.  NF-κB signaling pathways and their inhibition by MCV proteins. TNF, IL-18 and lipopolysaccharide (LPS) ligate to TNFR, IL-18R and TLR4, respectively. 
Ligation-induced activation of various receptors promote the recruitment of receptor proximal adaptor proteins and signaling to the IKK complex, composed 
of two catalytic subunits (IKKα and IKKβ). Signaling to IKK proceeds through TRAF/RIP complexes, generally in conjunction with TAK1, leading to canonical 
NF-κB signaling. Signaling to IKK may also proceed through TRAFs and NIK leading to the noncanonical NF-κB pathway. Activation of IKK results in IκB 
phosphorylation and degradation in the canonical pathway and consequently, nuclear translocation of phosphorylated NF-κB dimers. Those NF-κB dimers 
bind to DNA and regulate gene expression. Inhibition of NF-κB signaling pathways by viral MC54, MC159 and MC160 is indicated by red blunt arrows132
Postepy Hig Med Dosw (online), 2014; tom 68: 129-136
other processes. Therefore, NF-κΒ is commonly regarded as 
a pleiotropic factor [41]. Because many NF-κΒ target genes, 
including cytokines and growth factors, influence the host 
cell cycle, viruses have evolved strategies of interference 
with NF-κΒ activation. Additionally, NF-κΒ activation can be 
altered in order to evade the mechanisms that kill infected 
cells and limit viral replication. On the other hand, viruses 
are able to trigger apoptosis to increase virus spread [13]. 
Many studies have shown the modulation of apoptosis by 
MCV via MC159 protein belonging to intracellular inhibitors 
of NF-κΒ. Another intracellular NF-κΒ inhibitor encoded by 
MCV, MC160, interferes with its activation induced by TNF-α. 
Interleukin-18 (IL-18)-mediated signaling and interferon-γ 
(IFN-γ) production, in turn, are altered by an MCV-encoded 
ligand inhibitor, MC54 protein. MC54 binds IL-18, and was 
therefore named IL-18 binding protein (IL-18BP) [21].
modulatIon oF Il-18 and tnF-α sIgnalIng by mcv
Expression of the molecules that are able to bind cytokines 
and block host cell pathways is a well-known immunomodu-
latory strategy developed by viruses. Poxviral cytokine bind-
ing proteins, such as IL-18BPs, belong to the group of ligand 
inhibitors that intercept the interactions between cellular 
ligands and receptors and block the signaling pathways that 
may activate NF-κΒ [21]. IL-18, the target for IL-18BPs, is a 
potent antiviral agent that induces IFN-γ production from 
T cells and macrophages, activates natural killer (NK) cells, 
and regulates Th1 and Th2 responses [25]. IL-18 also activates 
the NF-κΒ pathway, which is significant for regulation of the 
expression of the IFN-γ gene by IL-18. The IL-18-induced 
NF-κΒ activation pathway became a target for poxviruses, 
including MCV (Fig. 1) [14].
Initially, IL-18BPs encoded by MCV, MC51, MC53 and MC54 
were characterized. The open reading frames (ORFs) of 
MC51, MC53 and MC54 share significant similarities in amino 
acid sequences and the proteins were included in one family. 
The MC51-53-54 family homologs were found among human 
and mouse proteins. Moreover, both of the ORFs of MC54 ho-
mologs showed 70% amino acid identity as well as the pres-
ence of a signal peptide and four N-glycosylation sites [43].
Further studies of Xiang and Moss [44] revealed that re-
combinant proteins MC53, MC54 and their two homologs 
encoded in human and mouse genomes are able to bind 
both human and murine IL-18 with high affinity. The bind-
ing of IL-18 resulted in the inhibition of IFN-γ production; 
moreover, the blockage of IFN-γ production by recombinant 
proteins in a dose-dependent manner was observed. How-
ever, additional research by Xiang and Moss (2001) showed 
that MC54 and human IL-18BP (hIL-18BP) have similar hIL-
18 binding sites, although their overall sequence identity is 
low. In contrast, two remaining proteins, MC51 and MC53, 
lack three or more of the critical amino acids, do not bind 
IL-18, and may interact with other undefined ligands [1,42]. 
Other studies demonstrated the presence of an additional 
C-terminal fragment of MC54 that can be cleaved by cel-
lular furin. The C-terminal tail of the full-length protein 
was found to be able to bind to glycosaminoglycans. Since 
glycosaminoglycans are present on the cell surface and in 
the extracellular matrix, the ability of MC54 to bind to the 
cell surface was also confirmed. This property may serve 
inactivation of IL-18 by the full-length MC54 in proximity 
of the site of infection whereas the short form is likely to 
inactivate IL-18 at distal locations [45]. The activity of MC54 
is suspected to be linked to the lack of an inflammatory re-
action around the skin lesions [23,36].
The ability of MC159 and MC160 proteins to interfere with 
TNF-dependent NF-κΒ signaling pathways was also studied 
(Fig. 1). MC159 is also able to inhibit late events of NF-κΒ ac-
tivation that are triggered by TNF-α since it prevents IκBβ, 
but not IκBα degradation and inhibits the expression of NF-
κΒ-regulated late genes, TNF-α and C-C chemokine ligand 
2 (CCL2), following TNF-α stimulation. Mutant MC159 does 
not bind TNF receptor-associated factor 2 (TRAF2), an adap-
tor protein, which is recruited by TNF receptor 1 (TNFR-1) 
upon its activation by TNF-α, leading to the activation of 
NF-κB. Thus, the NF-κΒ activation mediated by TNF cannot 
be inhibited. The production of proinflammatory molecules 
and immunoattractant factors is suppressed in infected cells 
probably because MC159 prevents them from responding to 
the TNF-α proinflammatory stimulus [24]. However, recent 
studies have revealed that MC159 is able to elevate an innate 
inflammatory reaction. Transgenic mice expressing MC159 
showed an increase in monocyte chemoattractant protein-1 
(MCP-1) expression. Moreover, MC159 was found to facili-
tate NF-κΒ activation induced by TNF-α and Toll-like recep-
tor 4 (TLR4) belonging to innate immune signaling recep-
tors. MC159 was also shown to regulate NF-κΒ induction via 
receptor-interacting protein 1 (RIP1) adaptor protein. Like 
TNFR1-associated death domain protein (TRADD), RIP1 is a 
crucial mediator in NF-κΒ activation by TNFR-1 and TLR4 
[5]. Recent data suggest the inhibition of NF-κΒ activation 
by the interactions between MC159 and IKK proteins, but 
not between MC159 and TRAF2 [32].
It was shown that MC160 is able to reduce TNF-α-mediated 
NF-κΒ activation that involves receptor-interacting proteins, 
TRAF2 and NF-κΒ-inducing kinase (NIK), as well as MyD88 
adaptor protein. MC160 interferes with IKK activation and 
reduces its phosphorylation in vitro. It may also disrupt IKK1 
and IKK2 interactions and its expression was found to cor-
relate with decreased level of IKK1, but not IKK2 [27].
the role oF mcv In apoptosIs modulatIon
MCV ability to modulate apoptosis has been widely dis-
cussed in recent years. There are two MCV-encoded pro-
teins, MC159 and MC160, belonging to intracellular NF-κΒ 
inhibitors, which interfere with cellular pathways that lead 
to apoptosis [21] (Fig. 2). Both of them belong to the viral 
Fas-associated death domain-like IL-1β converting enzyme 
(FLICE) inhibitory protein (vFLIP) family of viral inhibitors, 
which are also present in γ-herpesviruses and interfere with 
death receptor-signaled apoptosis [15,29].
In cells, counterparts of vFLIPs called cellular FLIPs (c-FLIPs) 
can be found. There are three isoforms of c-FLIPs, which 133
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contain two tandem death effector domains (DEDs) at the 
N-terminal end. DEDs are necessary for the recruitment of 
the death-inducing signaling complex (DISC), consisting of 
oligomerized receptors, adaptor molecule Fas-associated 
death domain (FADD), procaspase-8 (FLICE) and -10, and c-
FLIP. The formation of DISC results in the activation of pro-
caspase-8 and the subsequent cell death. DEDs play a role in 
the interactions between FADD, procaspase-8, -10 and c-FLIP, 
whereas the receptor-FADD interaction is mediated by the 
death domains (DDs) [reviewed in 28].
vFLIPs, which contain two DEDs, inhibit the recruitment of 
FLICE by CD95 (Fas), the death receptor, via the interaction 
of their DEDs with FADD. This interaction protects against 
death-receptor-induced apoptosis and may serve viral per-
sistence and oncogenesis [38]. 
It was also shown that DED domains of MC159 protect against 
death-receptor-induced apoptosis, and studies on the crystal 
structure of MC159 revealed that the interaction between 
the surface of MC159 containing the conserved charge triad, 
Fas and FADD appears to compete with self-association of 
FADD and disrupts the oligomerization of DISC by interaction 
with FADD molecules [2,46]. Other studies showed that two 
tandem DEDs of MC159 strictly associate with each other due 
to the presence of a conserved hydrophobic interface that 
can also be found in the tandem DEDs, the components of 
v-FLIPs, c-FLIPs, caspase-8 and caspase-10. Moreover, signifi-
cant homology of the packing interactions between the two 
domains of MC159 and between the Apaf-1 CARD domains 
and caspase-9 was found [17].
As mentioned above, MCV influences both apoptosis and 
the activation of NF-κΒ transcription factor. MC159 pre-
vents apoptosis via inhibition of protein kinase R (PKR), 
a viral dsRNA-activated serine/threonine kinase that 
mediates apoptosis in virus-infected cells, as well as in 
other non-infected cells. PKR-induced apoptosis relies 
on the FADD/caspase-8 and the mitochondrial caspase-9 
pathways. Upon dsRNA treatment, which triggers PKR-
mediated apoptosis, NF-κΒ transcription factor under-
goes activation via the induction of IKK [9]. MC159 was 
found to inhibit PKR-induced NF-κΒ activation and other 
downstream events stimulated by PKR without counter-
acting the antiviral action of PKR in response to poxvirus 
infection [10].
MC160, which induces IKK1 degradation, is stabilized by 
cellular heat shock protein 90 (Hsp90), which is required for 
IKK1 stabilization as well. In MC160-expressing cells, IKK1 
levels can be restored by Hsp90 overexpression, which may 
reverse IKK1 degradation. Thus, MC160 is seemingly able to 
compete with Hsp90. It was also shown that the N-terminal 
portion of MC160 contains DED, which interacts with pro-
caspase-8. Such interaction prevents procaspase-8-induced 
NF-κΒ activation [26].
conclusIons
Multiple strategies of MCV interference with the activa-
tion of NF-κB transcription factor, a key regulator of anti-
viral response, are related to the presence of viral proteins, 
which display anti-inflammatory properties and are linked 
to the persistence of MCV infections (Fig. 3). The interac-
tions between NF-κB and MCV immunomodulatory pro-
teins are crucial for viral immune evasion and should be 
studied extensively in order to find a target for an effective 
anti-MCV therapy.
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